Recent transcriptomic data indicated that anti-TNF-α treatment suppresses the CHI3L1 gene expression in the cells obtained from RA patients and YKL-40 might be an early indicator of non-response to anti-TNF-α treatment (79). This evidence concerns the gene CHI3L1 and rheumatoid arthritis.